$FLNA Q2 '26 Earnings Results & Recap Filana Therapeutics, Inc. reported a net loss of $8.6 million for the three months ended June 30, 2026, and $18.9 million for the six months ended June 30, 2026.
$FLNA Q2 '26 Earnings Results & Recap Filana Therapeutics, Inc. reported a net loss of $8.6 million for the three months ended June 30, 2026, and $18.9 million for the six months ended June 30, 2026.